Literature DB >> 10547590

Matrix metalloproteinases in tumour invasion and metastasis.

S Curran1, G I Murray.   

Abstract

The matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes, which are involved in the degradation of many different components of the extracellular matrix. The MMPs have been classified into different groups including collagenases, gelatinases, stromelysins, and others, particularly membrane-type MMPs, based mainly on the in vitro substrate specificity of individual MMPs. There is increasing evidence to indicate that individual MMPs have important roles in tumour invasion and metastasis. However, the current concept of the role of MMPs in tumour invasion is that they not only have a direct role in tumour invasion by facilitating extracellular matrix degradation, but as a consequence they also have an important role in maintaining the tumour micro-environment and thus promoting tumour growth. Inhibiting the action of MMPs represents a new therapeutic approach for the treatment of individual types of cancer and several broad-spectrum, low-molecular-weight MMP inhibitors are currently being assessed for clinical use. This review examines the role of MMPs in tumour invasion and metastasis, with an emphasis on studies of clinical relevance. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547590     DOI: 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  168 in total

1.  MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.

Authors:  Zhi-Hui Yang; Shi-Ning Li; Jin-Xing Liu; Qing-Xi Guo; Xing-Wang Sun
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  Potential of fluorescent metalloproteinase substrates for cancer detection.

Authors:  Roopali Roy; David Zurakowski; Susan Pories; Marcia L Moss; Marsha A Moses
Journal:  Clin Biochem       Date:  2011-10-06       Impact factor: 3.281

3.  Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Authors:  Lena Diaw; Mark Roth; Debra A Schwinn; Mary E d'Alelio; Lisa J Green; Joseph A Tangrea
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

4.  Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro.

Authors:  F Bernerd; D Asselineau; C Vioux; O Chevallier-Lagente; B Bouadjar; A Sarasin; T Magnaldo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue.

Authors:  Irene Vejgaard Sorensen; Claus Fenger; Henrik Winther; Niels T Foged; Ulrik Lademann; Nils Brünner; Pernille A Usher
Journal:  J Histochem Cytochem       Date:  2006-03-03       Impact factor: 2.479

Review 6.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

Authors:  Christian G Sauer; Alexandra Kappeler; Monika Späth; Jens J Kaden; Maurice S Michel; Doris Mayer; Uwe Bleyl; Rainer Grobholz
Journal:  Virchows Arch       Date:  2004-04-16       Impact factor: 4.064

8.  Matrix metalloproteinase inhibitor, MMI270 (CGS27023A) inhibited hematogenic metastasis of B16 melanoma cells in both experimental and spontaneous metastasis models.

Authors:  Tatsuhiko Kasaoka; Hiroko Nishiyama; Mikiko Okada; Motowo Nakajima
Journal:  Clin Exp Metastasis       Date:  2008-07-31       Impact factor: 5.150

9.  Multifunctional albumin nanoparticles as combination drug carriers for intra-tumoral chemotherapy.

Authors:  Mingjie Cui; Dominik J Naczynski; Margot Zevon; Craig K Griffith; Larisa Sheihet; Izmarie Poventud-Fuentes; Suzie Chen; Charles M Roth; Prabhas V Moghe
Journal:  Adv Healthc Mater       Date:  2013-03-12       Impact factor: 9.933

10.  Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.

Authors:  Yiwei Li; Mingxin Che; Sunita Bhagat; Kerrie-Lynn Ellis; Omer Kucuk; Daniel R Doerge; Judith Abrams; Michael L Cher; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.